SCHEMBL7130602

SCHEMBL7130602

CCCCOc1ccc(NC(=O)c2cc([N+](=O)[O-])ccc2Cl)cc1

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTT P42858 2/20 0.64
RECQL P46063 1/20 0.64
RORC P51449 6/20 0.63
MAPT P10636 5/20 0.63
KMT2A Q03164 5/20 0.63
MEN1 O00255 4/20 0.63
CYP3A4 P08684 2/20 0.63
MAPK1 P28482 2/20 0.63
PPARG P37231 2/20 0.63
SMN1; SMN2 Q16637 2/20 0.63
LMNA P02545 2/20 0.63
PKM P14618 2/20 0.63
TP53 P04637 1/20 0.63
CYP1A2 P05177 1/20 0.63
CYP2D6 P10635 1/20 0.63
CYP2C9 P11712 1/20 0.63
TSHR P16473 1/20 0.63
NFKB1 P19838 1/20 0.63
CYP2C19 P33261 1/20 0.63
THPO P40225 1/20 0.63

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7120591 0.91 TAS1R3 (0.70) RORCMAPTKMT2AMEN1CYP3A4
SCHEMBL11911348 0.85 MAPT (0.76) RORCMAPTKMT2AMEN1CYP3A4
SCHEMBL7128819 0.84 PPARG (0.63) HTTRORCMAPTKMT2AMEN1
SCHEMBL7122863 0.83 MAPT (0.62) HTTRORCMAPTKMT2AMEN1
SCHEMBL7130609 0.83 RORC (0.84) HTTRORCMAPTKMT2AMEN1
SCHEMBL27578953 0.83 GAA (0.73) RORCMAPTKMT2AMEN1CYP3A4
SCHEMBL7119644 0.83 PPARG (0.67) RORCMAPTKMT2AMEN1CYP3A4
SCHEMBL7118645 0.83 RORC (0.67) HTTRORCMAPTKMT2AMEN1
SCHEMBL7119973 0.83 PPARG (0.61) HTTRORCMAPTKMT2AMEN1
SCHEMBL7131095 0.82 PPARG (0.70) HTTRORCMAPTKMT2AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1440383-A PPAR gamma modulators SANKYO CO (JP) 2003-09-03 CN disclosed
US-20030134859-A1 PPAR-gamma modulator SANKYO COMPANY, LIMITED (JP) 2003-07-17 US disclosed
EP-1277729-A1 PPAR (GAMMA) MODULATORS Sankyo Company, Limited (JP) 2003-01-22 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030134859-A1 PPAR-gamma modulator PPARG, PPARA, PPARD HTT 4694/4885RECQL 4675/4885RORC 67/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.